2m 2m 2m 2m 2m 2m 2m
ALIGOS THERAPT (ALGS)
NASDAQ
$6.09-$0.27 (-4.31%)
Price as of Jul 14, 2026 8:32 AM EDT- $34.3MMarket Cap
- -26.81%1-Year Change
- BiotechnologyIndustry
ALIGOS THERAPT (ALGS)
$6.09-$0.27 (-4.31%)
ALGS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.36 | ||
Change | -$0.26 (-3.93%) | ||
Open | $6.54 | ||
High | $6.58 | ||
Low | $6.16 | ||
Previous Close | $6.62 | ||
Volume | 189,230 | ||
30-Day Average Volume | 306,168 | ||
1-Week Change | 8.72% | ||
1-Month Change | 20.45% | ||
1-Year Change | -26.81% | ||
3-Year Change | -73.50% | ||
5-Year Change | -98.32% | ||
Fundamentals | |||
Shares Outstanding | 5.4M | ||
Total Assets | $64.6M | ||
Market Cap | $34.3M | ||
Enterprise Value | $4.3M | ||
Period: QTR TTM FY | |||
Revenue | $2.8M | ||
Net Income | -$23.0M | ||
Free Cash Flow | -$23.1M | ||
EBIT | -$22.7M | ||
EBITDA | -$22.4M | ||
Net Working Capital | $36.3M | ||
EPS | -$2.21 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/19/2024 | ||
Earnings & Revenue